(Q43836905)

27 November 2017

Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder (English)

1 reference

27 November 2017

Norman B Schmidt

1

1 reference

27 November 2017

Kelly Wollaway-Bickel

2

1 reference

27 November 2017

John H Trakowski

3

1 reference

27 November 2017

Helen T Santiago

4

1 reference

27 November 2017

Michael Vasey

5

1 reference

27 November 2017

language of work or name

1 reference

1 January 2002

1 reference

Behaviour Research and Therapy

27 November 2017

1 reference

27 November 2017

40

1 reference

27 November 2017

67-73

1 reference

27 November 2017

1

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Efficacy of a brief psychosocial treatment for panic disorder in an active duty sample: implications for military readiness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Multicenter collaborative panic disorder severity scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Use of medication and in vivo exposure in volunteers for panic disorder research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Clinical effects of abrupt withdrawal from tri-cyclic antidepressants and monoamine oxidase inhibitors after long-term treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

Nonpsychiatric medical comorbidity, health perceptions, and treatment outcome in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

inferred from DOI database lookup

7 January 2021

based on heuristic

The effects of treatment compliance on outcome in cognitive-behavioral therapy for panic disorder: quality versus quantity.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-7967%2801%2900003-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-7967(01)00003-1

1 reference

27 November 2017

1 reference